Acute toxicity and patient-reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer.

Takashi IizumiHitoshi IshikawaYuta SekinoKeiichi TanakaDaichi TakizawaHirokazu MakishimaHaruko NumajiriMasashi MizumotoKei NakaiToshiyuki OkumuraHideyuki Sakurai

Published in: Journal of medical radiation sciences (2021)

There were no significant differences in adverse events or quality of life among the three fractionation schedules early after PBT.

Keyphrases

patient reported
prostate cancer
liver failure
radical prostatectomy
radiation therapy
respiratory failure
drug induced
oxidative stress
aortic dissection
hepatitis b virus
brain metastases
intensive care unit
small cell lung cancer
extracorporeal membrane oxygenation